Entecavir Combined Short-term Intravenous Hepatitis B Immune Globulin (HBIG) to Prevent Hepatitis B Recurrence After Liver Transplantation
Clinical trial NCT02417207 · UNKNOWN
Trial details
- NCT number
- NCT02417207
- Sponsor
- Third Affiliated Hospital, Sun Yat-Sen University
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2015-04-01
- Primary completion
- 2018-04-01
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.